- Management to discuss second quarter 2011 financial results -
Labopharm Inc. (TSX: DDS) (NASDAQ: DDSS) today announced that it will host a conference call on Thursday, August 4, 2011 at 8:30 a.m. (ET) to discuss its second quarter 2011 financial results. Labopharm will report its second quarter 2011 financial results via news release at approximately 7:00 a.m. (ET) the same day.
To access the conference call by telephone, dial 647-427-7450 or 1-888-231-8191. Please connect approximately 15 minutes prior to the beginning of the call to ensure participation. The conference call will be archived for replay until Thursday, August 11, 2011 at midnight. To access the archived conference call, dial 416-849-0833 or 1-855-859-2056 and enter the reservation number 87032649.
A live audio webcast of the conference call will be available at www.labopharm.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above web site for 30 days.
About Labopharm Inc.
Labopharm is focused on realizing value from its commercialized products and creating additional value by leveraging its emerging technology platforms to develop increasingly differentiated products. For more information, visit http://www.labopharm.com.
At The Equicom Group Lawrence Chamberlain Media and Investor Relations Tel: (416) 815-0700 ext. 257 lchamberlain@equicomgroup.com French: Joe Racanelli Tel: (514) 844-7997 jracanelli@equicomgroup.com
??? "Labopharm will receive a royalty of 5% on net sales of OLEPTROTM in the United States in excess of US$10 million in any calendar quarter. Net sales of OLEPTROTM in the United States for the most recent quarter ended March 31, 2011 were $908,000. "
So are they saying the company gets nothing until sales are 10X what the are today???
News 
Market Data 
Discover 
